Methods: In this single group pre-/post-test and one-month follow-up study, 10 AYAs with a primary sarcoma diagnosis participated in an open pilot of SFBT for their depression. Trained graduate-level social work interns delivered a structured four-session SFBT to participants with moderate or greater depressive symptoms (measured by the Patient Health Questionnaire, 9-item (PHQ-9)) at baseline. Core clinical measures included PHQ-9, the Generalized Anxiety Scale, 7-item (GAD-7), and the Herth Hope Index (HHI). Participants were evaluated at baseline, immediate post-intervention, and one-month follow-up. Statistical analysis using an intent-to-treat framework included descriptive statistics, pre- and post-intervention differences using paired samples t-test, and ANOVA to identify the pattern of difference in outcomes across three time points. Within-group small sample size corrected Hedges' g was estimated to evaluate SFBT's clinical significance.
Results: All participants completed four planned sessions and reported strong acceptability of SFBT. Statistically significant improvements were observed for pre- and post-treatment scores for depression (t(9)=5.65, p<0.001, g=0.95), anxiety (t(9)=5.75, p<0.001, g=0.92), and levels of hope (t(9)=7.61, p<0.001, g=1.57). These improvements were maintained at 1-month follow-up, with significant patterns of difference in study participants’ depression (F(2)=33.26, p<0.001), anxiety(F(2)=19.16, p<0.001), and levels of hope (F(2)=69.90, p<0.001) over time. Notably, the significant correlations in the change of hope score and scores of depression and anxiety suggest a signal of hope's therapeutic value in managing depression and anxiety for AYA cancer survivors.
Conclusions and Implications: SFBT is an acceptable intervention approach for depression (and anxiety) among AYAs diagnosed with cancer. SFBT offers a brief, strength-based, and hope-engendering approach to address mental health concerns among young adults diagnosed with cancer.